P3 Health Partners Inc.
NASDAQ:PIII
0.479 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 379.157 | 388.488 | 346.861 | 288.351 | 329.086 | 302.077 | 258.2 | 248.26 | 269.454 | 273.544 | 490,604.623 | 156.52 | 151.419 | 151.298 | 130.399 | 128.841 | 116.864 | 114.959 |
| Cost of Revenue
| 386.864 | 403.596 | 389.313 | 300.941 | 324.051 | 307.11 | 291.181 | 276.591 | 267.448 | 287.573 | 668.066 | 161.328 | 150.381 | 146.625 | 136.244 | 127.016 | 105.778 | 115.464 |
| Gross Profit
| -7.707 | -15.108 | -42.452 | -12.59 | 5.035 | -5.033 | -32.981 | -28.331 | 2.006 | -14.028 | 489,936.556 | -4.808 | 1.038 | 4.673 | -5.845 | 1.825 | 11.087 | -0.506 |
| Gross Profit Ratio
| -0.02 | -0.039 | -0.122 | -0.044 | 0.015 | -0.017 | -0.128 | -0.114 | 0.007 | -0.051 | 0.999 | -0.031 | 0.007 | 0.031 | -0.045 | 0.014 | 0.095 | -0.004 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 26.61 | 27.401 | 24.431 | 33.065 | 27.223 | 37.643 | 39.7 | 37.863 | 41.098 | 38.599 | 53,336.455 | 20.434 | 18.391 | 15.059 | 16.617 | 13.743 | 11.769 | 11.262 |
| Selling & Marketing Expenses
| 0.414 | 0.322 | 0.721 | 0.654 | 0.857 | 1.001 | 1.7 | 1.12 | 1.408 | 0.865 | 1,501.516 | 0.491 | 0.357 | 0.27 | 0.872 | 0.279 | 0.149 | 0.203 |
| SG&A
| 27.024 | 27.723 | 25.152 | 33.719 | 28.08 | 38.644 | 41.4 | 38.982 | 42.506 | 39.464 | 54,837.971 | 20.925 | 18.747 | 15.329 | 17.488 | 14.022 | 11.918 | 11.465 |
| Other Expenses
| 3.397 | -1 | 3.344 | 0.19 | -0.741 | 312.25 | 289.9 | 269.29 | 1.49 | 286.248 | 464,293.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 23.627 | 28.723 | 21.808 | 322.171 | 350.119 | 350.894 | 331.3 | 308.272 | 330.185 | 325.712 | 519,131.75 | 184.644 | 170.857 | 164.286 | 1.274 | 15.34 | 121.527 | 5.624 |
| Operating Income
| -31.334 | -43.831 | -64.26 | -33.82 | -21.033 | -48.817 | -536.5 | -60.012 | -912.187 | -52.168 | 60.55 | -28.124 | -19.438 | -12.988 | -4.281 | -13.515 | -4.663 | -6.13 |
| Operating Income Ratio
| -0.083 | -0.113 | -0.185 | -0.117 | -0.064 | -0.162 | -2.078 | -0.242 | -3.385 | -0.191 | 0 | -0.18 | -0.128 | -0.086 | -0.033 | -0.105 | -0.04 | -0.053 |
| Total Other Income Expenses Net
| 3.528 | -3.703 | -3.08 | 0.945 | -2.472 | 0.745 | -454.2 | -2.567 | -839.641 | -5.861 | -31,390.419 | -1.402 | -1.124 | -9.538 | 4.054 | -2.317 | -2.3 | -2.261 |
| Income Before Tax
| -27.806 | -47.534 | -67.34 | -36.877 | -27.356 | -52.158 | -530.5 | -65.329 | -903.106 | -60.79 | -31,329.869 | -34.168 | -24.968 | -24.651 | -0.227 | -15.831 | -6.963 | -8.391 |
| Income Before Tax Ratio
| -0.073 | -0.122 | -0.194 | -0.128 | -0.083 | -0.173 | -2.055 | -0.263 | -3.352 | -0.222 | -0.064 | -0.218 | -0.165 | -0.163 | -0.002 | -0.123 | -0.06 | -0.073 |
| Income Tax Expense
| 0.968 | 2.072 | 1.767 | 0.412 | 0.226 | 0.29 | 1.9 | -51.406 | -746.022 | -47.452 | -13.634 | 3.931 | 10.026 | 2.124 | 3.45 | 0.876 | -2.775 | -1.551 |
| Net Income
| -12.02 | -18.7 | -25.462 | -13.296 | -9.816 | -9.199 | -94.026 | -11.173 | -154.35 | -10.577 | 76.088 | -32.054 | -29.464 | -24.651 | -3.677 | -16.707 | -4.188 | -6.84 |
| Net Income Ratio
| -0.032 | -0.048 | -0.073 | -0.046 | -0.03 | -0.03 | -0.364 | -0.045 | -0.573 | -0.039 | 0 | -0.205 | -0.195 | -0.163 | -0.028 | -0.13 | -0.036 | -0.059 |
| EPS
| -0.088 | -0.16 | -0.27 | -0.12 | -0.091 | -0.22 | -2.26 | -0.27 | -3.71 | -0.25 | 1.83 | -0.46 | -0.43 | -0.37 | -0.058 | -0.25 | -0.063 | -0.11 |
| EPS Diluted
| -0.085 | -0.16 | -0.086 | -0.043 | -0.091 | -0.22 | -2.26 | -0.046 | -0.64 | -0.25 | 1.83 | -0.46 | -0.43 | -0.37 | -0.055 | -0.25 | -0.063 | -0.11 |
| EBITDA
| -9.641 | -22.292 | -42.626 | -11.909 | 0.006 | -27.181 | -48.3 | -38.197 | -39.011 | -30.416 | -33,850.005 | -26.265 | -17.885 | -12.656 | -4.099 | -13.269 | -4.474 | -5.951 |
| EBITDA Ratio
| -0.025 | -0.057 | -0.123 | -0.041 | 0 | -0.09 | -0.187 | -0.154 | -0.145 | -0.111 | -0.069 | -0.168 | -0.118 | -0.084 | -0.031 | -0.103 | -0.038 | -0.052 |